The GRID2 gene helps certain brain cells in the cerebellum connect and signal properly, which supports balance, coordination, and motor learning. If it does not work well, people may have unsteady walking, low muscle tone, unusual eye movements, developmental delay, or seizures. Some variants in the GRID2 gene are linked to inherited forms of cerebellar ataxia, a condition that affects movement control. This gene is mainly known in neurology and genetics rather than popular culture.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or control processes in the body. Some genes provide the directions for producing proteins, the parts of cells that do the work. Other genes mainly help determine when certain processes take place, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. To explore this topic in more detail, you can learn more in the LearnHub.
Overview
GRID2Gene function
What if the gene works
The GRID2 gene helps cerebellar nerve cells form and maintain normal connections. This supports balance, coordinated movement, and motor learning.
Risk
What if the gene does not work
Variants in the GRID2 gene are linked to balance and coordination problems, delayed motor development, and unusual eye movements. Effects can range from milder to more severe, influencing when symptoms begin and how much movement is affected.
Treatment
What does that mean for your treatment
For people with a pathogenic or loss-of-function variant in the GRID2 gene, no GRID2-specific treatment or drug-selection approach is currently established. The GRID2 gene is being studied as a research target in cerebellar signaling, but this has not yet changed routine care.
Conditions associated with GRID2
Gene function
What if the gene works
Your cerebellum helps with balance, smooth movement, and motor learning. The GRID2 gene supports this system by helping certain brain cells connect and communicate in an orderly way. This background helps explain what the GRID2 gene does in the cerebellum during everyday movement.
The GRID2 gene helps Purkinje cells, a type of cerebellar nerve cell, form stable links with incoming nerve fibers. These links let movement information arrive at the right place for smooth, well timed control.
Its protein sits at contact points between nerve cells and helps line up the two sides of the connection. This supports clear signaling as brain cells pass movement messages through the cerebellum.
This gene also helps maintain cerebellar connections after they are formed. Steady upkeep supports balance, posture, and small movement adjustments during daily activities.
By shaping how cerebellar cells respond during practice, the GRID2 gene supports motor learning. This is part of how your brain fine tunes actions like walking on uneven ground or reaching for a cup.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body reacts to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GRID2 gene can change the receptor protein’s shape, make it unusually short, or keep it from reaching the surface of Purkinje cells, the nerve cells that help coordinate movement. In terms of GRID2 gene variant effects, some changes only partly reduce signaling between cells, while more severe variants can nearly abolish it. This functional range often matches the clinical range, with stronger loss of function linked to earlier or more noticeable balance and coordination problems (cerebellar ataxia).
How variants are linked to conditions
Pathogenic variants in the GRID2 gene can cause a rare inherited cerebellar ataxia with shrinkage of the balance center of the brain, often leading to unsteady walking, poor coordination, and delayed motor milestones. Some people also have unusual eye movements, low muscle tone, speech delay, or intellectual disability. When disease-causing variants are found in both copies of the GRID2 gene, the result can confirm this diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and instead represent part of natural human variation. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce risk related to the GRID2 gene. For many living with a disease-causing GRID2 change, the main risk comes from the genetic change itself, while symptoms can vary from one person to another.
Inheritance of GRID2 variants
For families trying to understand how GRID2 gene variants are inherited, the pattern can differ by the specific GRID2-related condition. Some well-established conditions linked to the GRID2 gene follow an autosomal recessive pattern, which means a child inherits one altered copy from each parent. Other GRID2-related conditions have been reported with autosomal dominant inheritance, where one altered copy can be enough to cause the condition and it can be passed from an affected parent to a child. This means the inheritance pattern for the GRID2 gene is not the same in every family.
What does my GRID2 result mean for my family?
Changes in the GRID2 gene have been linked to more than one inherited nerve and balance condition, so what it means for relatives depends on the exact result and the condition involved. In some families, parents may be healthy carriers and brothers or sisters could also be affected or be carriers. In other families, a changed GRID2 gene can be passed from an affected parent to a child, so close relatives may also carry the same change.
Genetic information
Genetic testing
How you find out about variants
To look for variants in the GRID2 gene, doctors use GRID2 genetic testing on a blood or saliva sample. A lab reads the gene's DNA code and compares it with the usual sequence to identify variants that may help explain symptoms or confirm whether a known family variant is present.
When should I consider getting a genetic test?
Consider testing for changes in the GRID2 gene when there are unexplained balance and coordination problems, delayed motor development, low muscle tone, or unusual eye movements, especially if brain scans show changes in the cerebellum. Testing can also help clarify a diagnosis when similar symptoms run in the family.
A genetic result is only one part of your health story
Genetic results can be helpful, but what they tell you depends on both the condition and the kind of variant involved. Many other factors also shape how the body works over time, including age, lifestyle, environment, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is broken down, moved through the body, or how strongly it acts at its target, so the same treatment may work better for one person than another. This is common and can influence how well a medicine helps, how long its effects last, or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way medications work. By looking at patterns between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence either how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the GRID2 gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding medication choices, so general questions about medicines or side effects are best discussed with your doctor. Seek medical advice if a treatment is not working as expected, causes new symptoms, or you are worried about how your medicines fit with your overall health.
History
GRID2 came to medical attention through studies of movement and balance problems in mice, especially the well known Lurcher mouse model used in neuroscience research. In the 1990s, researchers identified the GRID2 gene and linked it to the glutamate receptor delta 2 protein in the cerebellum, the part of the brain that helps coordinate movement. From these first observations, research expanded steadily. Scientists then showed that changes affecting GRID2 could disrupt cerebellar development in animal models, which made the gene important in studies of inherited ataxia. Later, rare variants and deletions involving the GRID2 gene were reported in people with developmental and coordination differences. These findings helped connect earlier laboratory work with human genetic medicine.